Cosmetic Regulation Update's Link With OTC Drug User Fees Clear At Hearing
This article was originally published in The Rose Sheet
Executive Summary
Members of the House Health Subcommittee suggest their support for potential OTC monograph reform legislation depends on including provisions that would add substantial details to FDA's oversight of cosmetics manufacturers and a related user fee program.